There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC A61K31/675
Pages in category "CPC A61K31/675"
The following 42 pages are in this category, out of 42 total.
2
- 20250152610. Imidazolate Gold Comp (University of Cincinnati)
- 20250161335. Drug (Shanghai Hep Pharmaceutical ., .)
- 20250161336. Treatment Ad (SymBio Pharmaceuticals Limited)
- 20250170155. Nucleoside Derivatives (Shionogi & ., .)
- 20250177422. Co-administration Co (ZYLORION HEALTH .)
- 20250186467. Methods Treating Me (ROME Therapeutics, .)
- 20250186468. Method T (ASCENTAWITS PHARMACEUTICALS, .)
- 20250195548. New Use (KANCERA AB)
- 20250195549. New Use (KANCERA AB)
- 20250205256. 5-meo-dmt Use (GH RESEARCH IRELAND LIMITED)
- 20250205257. Cyclic Cidofovir Or Prodrug There (VIROVET NV)
- 20250205258. Deriva (SHANGHAI MEWSGEN BIOTECHNOLOGY .,)
A
J
S
- SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Patent Application Trends in 2024
- SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Patent Application Trends in 2025
- SHANGHAITECH UNIVERSITY Patent Application Trends in 2025
- Slayback Pharma LLC Patent Application Trends in 2024
- Slayback Pharma LLC Patent Application Trends in 2025
T
- TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent Application Trends in 2024
- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM Patent Application Trends in 2024
- The Board of Regents of the University of Texas System Patent Application Trends in 2024
- The General Hospital Corporation Patent Application Trends in 2024
- The Johns Hopkins University Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN Patent Application Trends in 2024
- THE UNIVERSITY OF CHICAGO Patent Application Trends in 2025